Palmirotta R - Search Results

1

Application of "omics" sciences to the prediction of bone metastases from breast cancer: State of the art.

Gentile M, Centonza A, Lovero D, Palmirotta R, Porta C, Silvestris F, D'Oronzo S. Gentile M, et al. Among authors: palmirotta r. J Bone Oncol. 2020 Nov 5;26:100337. doi: 10.1016/j.jbo.2020.100337. eCollection 2021 Feb. J Bone Oncol. 2020. PMID: 33240786 Free PMC article. Review.

2

Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy.

Savonarola A, Palmirotta R, Guadagni F, Silvestris F. Savonarola A, et al. Among authors: palmirotta r. Pharmacogenomics J. 2012 Aug;12(4):277-86. doi: 10.1038/tpj.2012.28. Epub 2012 Jul 3. Pharmacogenomics J. 2012. PMID: 22760589 Review.

3

Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.

Rizzo FM, Palmirotta R, Marzullo A, Resta N, Cives M, Tucci M, Silvestris F. Rizzo FM, et al. Among authors: palmirotta r. BMC Cancer. 2016 Feb 11;16:87. doi: 10.1186/s12885-016-2111-x. BMC Cancer. 2016. PMID: 26867653 Free PMC article.

4

Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition.

Palmirotta R, Cives M, Della-Morte D, Capuani B, Lauro D, Guadagni F, Silvestris F. Palmirotta R, et al. Oxid Med Cell Longev. 2016;2016:3031459. doi: 10.1155/2016/3031459. Epub 2016 Jun 9. Oxid Med Cell Longev. 2016. PMID: 27379175 Free PMC article. Review.

5

Characterization of a Rare Nonpathogenic Methylenetetrahydrofolatereductase (MTHFR) Gene Mutation p.Lys215del in a Southern Italian family.

Palmirotta R, Lovero D, Silvestris E, Simone V, Lanotte L, Quaresmini D, Silvestris F. Palmirotta R, et al. Hum Mutat. 2017 Jan;38(1):120-121. doi: 10.1002/humu.23132. Epub 2016 Oct 21. Hum Mutat. 2017. PMID: 27768236 No abstract available.

6

[Genomics of lung adenocarcinoma: pathogenetic significance and clinical applications.].

Palmirotta R, Acquafredda S, Argentiero A, Carella C, Lanotte L, Pappagallo N, Quaresmini D, Silvestris F. Palmirotta R, et al. Recenti Prog Med. 2016 Dec;107(12):652-672. doi: 10.1701/2502.26236. Recenti Prog Med. 2016. PMID: 27997009 Review. Italian.

7

ALK gene alterations in cancer: biological aspects and therapeutic implications.

Palmirotta R, Quaresmini D, Lovero D, Silvestris F. Palmirotta R, et al. Pharmacogenomics. 2017 Feb;18(3):277-292. doi: 10.2217/pgs-2016-0166. Epub 2017 Jan 23. Pharmacogenomics. 2017. PMID: 28112990

8

Characterization of a rare nonpathogenic sequence variant (c.1905C>T) of the dihydropyrimidine dehydrogenase gene (DPYD).

Palmirotta R, Lovero D, Silvestris E, Carella C, Felici C, Quaresmini D, Cafforio P, Silvestris F. Palmirotta R, et al. Int J Biol Markers. 2017 Jul 24;32(3):e357-e360. doi: 10.5301/ijbm.5000260. Int J Biol Markers. 2017. PMID: 28430339 Free article.

9

Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).

Palmirotta R, Lovero D, Silvestris E, Felici C, Quaresmini D, Cafforio P, Silvestris F. Palmirotta R, et al. Cancer Genomics Proteomics. 2017 May-Jun;14(3):173-179. doi: 10.21873/cgp.20029. Cancer Genomics Proteomics. 2017. PMID: 28446532 Free PMC article.

10

Desmoid Tumors in Familial Adenomatous Polyposis.

DE Marchis ML, Tonelli F, Quaresmini D, Lovero D, Della-Morte D, Silvestris F, Guadagni F, Palmirotta R. DE Marchis ML, et al. Among authors: palmirotta r. Anticancer Res. 2017 Jul;37(7):3357-3366. doi: 10.21873/anticanres.11702. Anticancer Res. 2017. PMID: 28668823 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters